若想读中文，请往下滑，中文在下方。

What are ReCODE and PreCODE?

ReCODE is the acronyms of Reversal of Cognitive Decline; PreCODE is the acronyms of Prevention of Cognitive Decline.

Apollo Health’s PreCODE  and /or ReCODE are personalized protocol programs, guided by Dr. Dale Bredesen. Thus, PreCODE and ReCODE are uniquely called Bredesen Protocol. 

Who can participate at PreCODE ? 

The PreCODE Program is designed to prevent cognitive decline and is perfect for adults of any age with family history of dementia, risk factors such as pre-diabetes or inflammation, and for all of us who are over 45 years of age and who would like to optimize their brain health and prevent cognitive decline. 

Who can participate at ReCODE?

ReCODE program delivers personalized information and resources for those experiencing cognitive decline associated with subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and early Alzheimer’s disease and who are seeking a reversal of symptoms and brain health optimization with the Bredesen Protocol.

Risk Factors Cognoscopy

Dr. Bredesen said: “Think about it like 36 holes in the roof,  you can’t just plug one hole.” That means no any one drug treats cognitive decline and/or Alzheimer’s disease. Comprehensive therapy program must be implemented. Each program helps you identify each potential contributors – risk factors, including 36 interventions that were assembled for each patient, based on extensive testing (blood, urine, genes), as well as personal preferred cognitive assessment. As with other chronic illnesses like heart disease and cancer, cognitive changes might be due to an array of contributing imbalances–an “extensive network of molecular interactions,” according to Bredesen’s paper, “Reversal of Cognitive Decline: A Novel Therapeutic Program,” published in the September 2014 Aging.

Age is the primary risk factor for cognitive decline. As aging, the metabolic function is getting slow, which impacts for brain function.  In addition to aging, other risk factors include family history-DNA genes, metabolic syndrome, inflammation, apnea, hypoxygen, education level, brain injury, exposure to pesticides or toxins, physical inactivity, etc. Many chronic conditions are associated with cognitive decline, such as Parkinson’s disease, MS, heart disease and stroke, osteoporosis, thyroid dysfunction, and diabetes . Insulin has been shown to play a role in plasticity, the brain’s ability to respond to a myriad of chemicals and other forces from within and outside the body.  Individuals with increased insulin levels or insulin resistance, associated with Type 2 diabetes, have a higher risk for Alzheimer’s disease.

A cognoscopy is a term coined by Dr. Bredesen, that refers to a simple assessment, which uses a combination of laboratory and cognitive testing that identifies the contributors to cognitive decline or risk for decline. We all know that, when we turn 50 years old, we should have a colonoscopy, so that we can detect and treat colon cancer early, thus avoiding advanced, life-threatening cancer.  But what about our brains?  Just as with colon cancer, the pathology behind neurodegeneration, including Alzheimer’s, takes many years — often decades to develop, providing for an extended prodromal period in which we can effectively intervene.  The good news is that we can now check our risk and intervene as early as possible to identify if we have emerging contributors that are silently contributing to neurodegenerative pathology.

How to Participate at the Program？

Option 1:  You can go to Apollo Health website: https://www.apollohealthco.com/know-your-cq/ to do the Cq Assessment. If you get low score, you can sign in PreCODE  program. If you already diagnosed for MCI or Alzheimer’s disease, you can sign in ReCODE program.

Option 2:  If you have language bar or some other reason, you can directly contact me as your specialized nutritionist. I will help you to manage the whole program process. We work together to fight Alzheimer’s disease as a rarely disease in the future. 

什么是 ReCODE 和 PreCODE？

ReCODE 是“逆转认知衰退”每个英文词的首字母缩写； PreCODE 是“预防认知衰退”每个英文词的首字母缩写。

Apollo 健康机构的PreCODE 和/或 ReCODE 是在美国著名的神经医生 Dr. Dale Bredesen 团队指导下的个性化自然疗法计划方案。因此，PreCODE 和 ReCODE 被独特地称为 Bredesen 协议。

谁可以参加PreCODE计划？

PreCODE 计划意旨提早预防认知能力下降，非常适合有痴呆家族史或带有APOE4基因的人、糖尿病前期或炎症等风险因素的任何年龄段的成年人，以及我们所有45岁以上，且希望优化他们的大脑健康并防止认知能力下降。

谁可以参加ReCODE计划?

ReCODE计划为那些正在经历有认知障碍症状 (SCI)、轻度认知障碍 (MCI) 和早期阿尔茨海默病相关的认知衰退，以及正在寻求通过 Bredesen 协议逆转症状和优化大脑健康的人提供个性化信息和资源。

危险因素筛查

Dr. Bredesen说：“想-想若屋顶上有 36 个洞，你不能只堵上一个洞。” 这意味着没有任何一种药物可以治疗认知能力下降和阿尔茨海默病。必须实施综合治疗方案. 每个计划都可以帮助您识别出每个潜在的贡献者 – 风险因素，同时包括一些基础测试(血， 尿， 基因）和个人选择的认知评估，为每位患者组装各种干预措施。这与心脏病和癌症等其他慢性疾病一样，认知变化可能是由于一系列不平衡造成的——根据 Dr. Bredesen在2014年9月发表的论文:“认知衰退的逆转：一种新的治疗计划”，他说这是一种“广泛的分子相互作用网络”。

年龄是认知能力下降的主要危险因素。随着年龄的增长，新陈代谢功能变慢，影响大脑功能。除年龄衰老外，其它风险因素包括家族史-DNA基因、代谢综合征、炎症、呼吸暂停、缺氧、教育水平、脑损伤、接触杀虫剂或毒素、缺乏运动等。许多慢性疾病与认知能力下降有关，如帕金森病、多发性硬化症、心脏病和中风、骨质疏松症、甲状腺功能障碍和糖尿病。胰岛素已被证明在可塑性中发挥作用，即大脑对来自身体内外的无数化学物质和其它力量作出反应的能力。与2型糖尿病相关的胰岛素水平或胰岛素抵抗升高的个体，患阿尔茨海默病的风险更高。

认知功能筛查（cognoscopy)是Dr. Bredesen创造的一个术语，指的是危险因素的评估，它使用实验室和认知测试的组合来识别导致认知下降或下降风险的因素。我们都知道，到了50岁的时候，我们应该做一次结肠镜检查，这样才能及早发现和治疗结肠癌，从而避免晚期、危及生命的癌症。那么我们的大脑呢？就像结肠癌一样，包括阿尔茨海默症在内的神经退行性病变背后的病理学需要很多年发展——通常是10-20年的发展，从而提供了一个延长的前驱期，我们可以在此期间进行有效干预。好消息是，我们现在可以筛查导致认知下降的风险，并尽早进行干预，以确保我们不断阻断一些危险因素默默地促成了神经退行性疾病。

怎样参加PreCODE/ReCODE计划?

选择 1：您可以访问 Apollo Health 网站：https://www.apollohealthco.com/know-your-cq/ 进行认认知（Cq）评估。如果您获得低分，您可以申请登记 PreCODE计划。如果您已经被诊断出患有MCI或阿尔茨海默症，您可以登记ReCODE计划。每年费用可以在https://www.apollohealthco.com 网页中查找出来。

选择 2：如果您有语言问题（英语）或其它原因，您可以直接联系我作为您的认知功能修复的专长营养师。我是APOLLO Health机构注册的营养师，专长调理认知功能下降和阿尔茨海默症。我将帮助您管理整个计划，我们共同努力抵抗阿尔茨海默症。在未来，要把它变成一种罕见的疾病，而不是像现在这样高发病率。 痴呆或阿尔茨海默症并不是不治之症，越早干预，康复越快。Wechat: sally9559; Email: sally_tng@yahoo.com.